氨甲环酸在美容整形手术中影响的系统综述与荟萃分析
该系统综述与荟萃分析纳入14项研究、820例患者,评估氨甲环酸在美容整形手术中对出血和美学效果的影响。荟萃分析显示氨甲环酸与平均失血量减少26.3 mL相关(95% CI,-40.0至-12.7 mL;P < 0.001),并提示术后血肿 odds 有下降趋势(OR,0.280;95% CI,0.076-1.029;P = 0.055)。其他结局因报告异质性未能荟萃分析,但部分研究报告术后瘀斑、引流量和手术部位质量改善。
要点
- 氨甲环酸与美容整形手术平均失血量减少26.3 mL相关。
- 术后血肿 odds 呈下降趋势但未达统计学显著性(P = 0.055)。
- 部分研究报告术后7天内瘀斑显著减少及引流量降低。
核心结论
- 氨甲环酸与美容整形手术失血量减少相关,并提示术后血肿形成 odds 有下降趋势。
- 氨甲环酸的使用可能提高患者对术后恢复的满意度并降低血肿清除等相关并发症的费用。
研究设计与样本
- 系统综述与荟萃分析,检索评估氨甲环酸在美容整形手术中应用的研究。
- 共纳入14项研究,涉及鼻整形(6项)、除皱术(3项)、吸脂(3项)、乳房缩小术(1项)和眼睑成形术(1项)。
- 共820例患者,其中446例(54.4%)接受氨甲环酸。
主要发现
- 荟萃分析显示氨甲环酸与平均失血量减少26.3 mL相关(95% CI,-40.0至-12.7 mL;P < 0.001)。
- 氨甲环酸与术后血肿 odds 下降趋势相关(OR,0.280;95% CI,0.076-1.029;P = 0.055)。
- 7项研究中有5项发现术后7天内瘀斑水平显著降低。
- 3项研究发现术后引流量有统计学显著减少。
- 1项研究报告接受氨甲环酸的患者手术部位质量显著改善(P = 0.001)。
临床怎么用
- 在美容整形手术中可考虑使用氨甲环酸以减少围手术期失血量。
- 对术后血肿风险的潜在降低需结合当前证据强度个体化评估。
局限性
- 其他结局因报告异质性未能进行荟萃分析。
- 术后血肿 odds 下降趋势未达统计学显著性(P = 0.055)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent evidence suggests tranexamic acid (TXA) may improve outcomes in aesthetic surgery patients. OBJECTIVES: This systematic review aimed to investigate the impact of TXA use in aesthetic plastic surgery on bleeding and aesthetic outcomes. METHODS: A systematic literature search was conducted to identify studies evaluating TXA use in aesthetic plastic surgery. The primary outcome of interest was perioperative bleeding, reported as total blood loss (TBL), ecchymosis, and hematoma formation. Meta-analyses analyzing TBL and postoperative hematoma were performed. RESULTS: Of 287 identified articles, 14 studies evaluating TXA use in rhinoplasty (6), rhytidectomy (3), liposuction (3), reduction mammaplasty (1), and blepharoplasty (1) were included for analysis. Of 820 total patients, 446 (54.4%) received TXA. Meta-analysis demonstrated TXA is associated with 26.3 mL average blood loss reduction (95% CI, -40.0 to -12.7 mL; P < 0.001) and suggested a trend toward decreased odds of postoperative hematoma with TXA use (odds ratio, 0.280; 95% CI, 0.076-1.029; P = 0.055). Heterogeneity among reporting of other outcomes precluded meta-analysis; however, 5 of 7 studies found significantly decreased postoperative ecchymosis levels within 7 days of surgery, 3 studies found statistically significant reductions in postoperative drain output, and 1 study reported significantly improved surgical site quality for patients who received TXA (P = 0.001). CONCLUSIONS: TXA is associated with decreased blood loss and a trend toward decreased hematoma formation in aesthetic plastic surgery. Its use has the potential to increase patient satisfaction with postoperative recovery and decrease costs associated with complications, including hematoma evacuation.
引用
- Laikhter E, Comer CD, Shiah E, et al. A Systematic Review and Meta-Analysis Evaluating the Impact of Tranexamic Acid Administration in Aesthetic Plastic Surgery. Aesthet Surg J. 2022. PMID: 34486647. doi:10.1093/asj/sjab333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。